Rezultati pretrage - Jean‐Jacques Body

Detaljiziraj rezultate
  1. 1
    Increased fracture rate in women with breast cancer: a review of the hidden risk

    Increased fracture rate in women with breast cancer: a review of the hidden risk od Jean‐Jacques Body

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease

    Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease od Jean‐Jacques Body

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    Epinephrine is a Hypophosphatemic Hormone in Man. PHYSIOLOGICAL EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID HORMONE, AND CALCITONIN

    Epinephrine is a Hypophosphatemic Hormone in Man. PHYSIOLOGICAL EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID HORMONE, AND CALCITONIN od Jean‐Jacques Body, Philip E. Cryer, Kenneth P. Offord, Hunter Heath

    Izdano 1983
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Bone health in cancer patients: ESMO Clinical Practice Guidelines

    Bone health in cancer patients: ESMO Clinical Practice Guidelines od Robert E. Coleman, Jean‐Jacques Body, Matti Aapro, Peyman Hadji, Jørn Herrstedt

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

    Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody od Roger von Moos, Luís Costa, Eva González‐Suárez, Evangelos Terpos, Daniela Niepel, Jean‐Jacques Body

    Izdano 2019
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  6. 6
    Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

    Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer od Komal Waqas, Joana Lima Ferreira, Elena Tsourdi, Jean‐Jacques Body, Peyman Hadji, M. Carola Zillikens

    Izdano 2021
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  7. 7
    Increased Dickkopf-1 expression in breast cancer bone metastases

    Increased Dickkopf-1 expression in breast cancer bone metastases od Nathalie Voorzanger‐Rousselot, Delphine Goehrig, Fabrice Journé, Valérie Doriath, Jean‐Jacques Body, Philippe Clézardin, Patrick Garnero

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

    The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts od Hichame Id Boufker, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean‐Jacques Body, Fabrice Journé

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases

    Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases od Jean‐Jacques Body, Geoffrey C. Quinn, Susan Talbot, Emma Booth, Gaston Demonty, Aliki Taylor, Justyna Amelio

    Izdano 2017
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  10. 10
    Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)

    Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS) od Julien Paccou, Elena Tsourdi, Christian Meier, Andrea Palermo, Jessica Pepe, Jean-Jacques Body, M. Carola Zillikens

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  11. 11
    Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

    Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie... od Jean‐Jacques Body, Ingo Diel, M. Lichinitzer, A. F Lazarev, Martin Pecherstorfer, R. Bell, Debu Tripathy, B. Bergström

    Izdano 2004
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

    Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS od Athanasios D. Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya Khan, M. Carola Zillikens, Jean-Jacques Body

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  13. 13
    Which treatment to prevent an imminent fracture?

    Which treatment to prevent an imminent fracture? od Laura, Iconaru, Felicia, Baleanu, Alexia, Charles, Aude, Mugisha, Florence, Benoit, Murielle, Surquin, Rafik, Karmali, Jean-Jacques, Body, Pierre, Bergmann

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  14. 14
    Loading and Skeletal Development and Maintenance

    Loading and Skeletal Development and Maintenance od P. Bergmann, Jean‐Jacques Body, S. Boonen, Y. Boutsen, J.-P. Devogelaer, Stefan Goemaere, JM Kaufman, Jean‐Yves Reginster, Serge Rozenberg

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

    A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. od Jean-Jacques Body, Thierry Façon, Robert E. Coleman, Allan Lipton, F. Geurs, Michelle Fan, Donna Holloway, Mark Peterson, Pirow Bekker

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

    Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases od Jean‐Jacques Body, Ingo Diel, М. Р. Личиницер, E.D. Kreuser, W. Dornoff, В. А. Горбунова, M. Budde, B. Bergström

    Izdano 2003
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

    Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates od Karim Fizazi, Allan Lipton, Xavier Mariette, Jean‐Jacques Body, Yasmin Rahim, Julie R. Gralow, Guozhi Gao, Ling Wu, Winnie Sohn, Susie Jun

    Izdano 2009
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

    Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club od Michaël R. Laurent, Stefan Goemaere, Charlotte Verroken, Pierre Bergmann, Jean‐Jacques Body, Olivier Bruyère, Étienne Cavalier, Serge Rozenberg, Bruno Lapauw, Evelien Gielen

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  19. 19
    Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

    Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases od Ariadne Bosman, Andrea Palermo, Julien Vanderhulst, Suzanne M. Jan de Beur, Seiji Fukumoto, Salvatore Minisola, Weibo Xia, Jean‐Jacques Body, M. Carola Zillikens

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  20. 20
    Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride

    Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride od Hubertus I.J. Harinck, O. L. M. Bijvoet, AndréS.T. Plantingh, Jean‐Jacques Body, Jan Willem F. Elte, H.P. Sleeboom, J. Wildiers, Jan P. Neijt

    Izdano 1987
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: